During the trials, enrolled subjects will get experimental shots or a placebo, and investigators will observe whether those who received the vaccine develop infections and illness at lower rates. The vaccine, which was co-developed by the pharmaceutical giant Pfizer and the German company BioNTech, is among front-runner efforts worldwide to develop immunizations for COVID-19 that are currently conducting or preparing to start phase III clinical trials-late-stage studies that test for efficacy and safety.* Six of these efforts are backed by Operation Warp Speed, a Trump administration program with the optimistic goal of beginning mass inoculations against the disease in the U.S. “People are fed up with this disease and very motivated to help.”
Operation warp speed vaccine trial#
The more than 1,000 names on the waiting list suggest the local response to the trial “has been outstanding,” says Mark Mulligan, an infectious disease specialist who directs NYU Langone’s Vaccine Center. In late July, volunteers began receiving doses of a potential COVID-19 vaccine in the latest stage of a clinical trial at NYU Langone Health in New York City.
In this story, Scientific American describes how the fast-track vaccine trials work and how they measure effectiveness and safety. Centers for Disease Control and Prevention just alerted states to prepare for a novel coronavirus vaccine as early as November.
0 kommentar(er)
